Pridinol - CISMeF

Preferred Label : Pridinol;

NCIt definition : An orally bioavailable, blood-brain permeable muscarinic receptor antagonist, with muscle-relaxing and antiparkinsonian activity. Upon oral administration, pridinol targets, binds to and blocks muscarinic receptors located on postganglionic parasympathetic nerve endings and on smooth muscle cells. This blocks the activity of acetylcholine (ACh) and causes its muscle relaxant effects. This may relief involuntary movements, spasms and muscle stiffness in Parkinson's disease and other neuromuscular disorders.;

UNII : 9E75Q6SUUB;

InChIKey : RQXCLMGKHJWMOA-UHFFFAOYSA-N;

CAS number : 511-45-5;

Chemical formula : C20H25NO;

Details

Origin ID

C73319;

UMLS CUI

C0071968;

Currated CISMeF NLP mapping
- Pridinol [ICD-11 Extension code]
- Pridinol [ICHI extension code]
- Pridinol [SMS substance]
- pridinol [Substance BNPC]
- pridinol [MeSH concept]
- pridinol [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Pridinol [ICD-11 Extension code]
- pridinol [ATC Code]
- pridinol [Substance BNPC]
- pridinol [MeSH Supplementary Concept]
- pridinol [MeSH concept]
Validated automatic mappings to BTNT
- pridinol [ATC Code]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients